IIM
REGN icon

Ironwood Investment Management’s Regeneron Pharmaceuticals REGN Stock Holding History

Ironwood Investment Management’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-200
Closed -$210K – 175
2024
Q2 		$210K Buy
+200
New +$194K 0.11% 145
2023
Q3 		– Sell
-380
Closed -$273K – 170
2023
Q2 		$273K Buy
+380
New +$293K 0.16% 130

Other funds holding REGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Ironwood Investment Management's REGN Position: Q3 2024 in Review

Ironwood Investment Management sold out of Regeneron Pharmaceuticals (REGN) in Q3 2024, closing a stake of 200 shares — an estimated $210K sold.

Ironwood Investment Management first reported a position in REGN in Q2 2023 and held it in 2 quarters. The position peaked at $273K in Q2 2023. 1,389 funds tracked by Wall St. Rank hold REGN as of Q3 2024.

  • Ironwood Investment Management reported no remaining Regeneron Pharmaceuticals position as of Q3 2024 after selling out during the quarter.
  • Ironwood Investment Management sold 200 Regeneron Pharmaceuticals shares in Q3 2024, an estimated $210K.
  • Ironwood Investment Management first reported a position in Regeneron Pharmaceuticals in Q2 2023 and held it in 2 quarters.
  • Ironwood Investment Management's Regeneron Pharmaceuticals position peaked at $273K in Q2 2023.
  • 1,389 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q3 2024.

Based on Ironwood Investment Management's 13F filing for Q3 2024, filed 14 Nov 2024.